A.G. Schneiderman Announces Settlement With Endo Health Solutions Inc. & Endo Pharmaceuticals Inc. Over Marketing Of Prescription Opioid Drugs
NEW YORK - Attorney General Eric T. Schneiderman today announced an agreement with Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. ("Endo"), which make and sell the long-acting opioid, Opana ER. The agreement requires Endo to cease all misrepresentations regarding the properties of Opana ER, to describe accurately the risk of addiction to Opana ER, and to summarize studies regarding Opana ER on its website. Endo must also create a program that will prevent its sales staff from promoting this powerful narcotic painkiller to health care providers who may be involved in the abuse and illegal diversion of opioids.
- Date:March 3, 2016
- Agency:New York Attorney General
- State Enforcement Agencies